Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07011966 · ClinicalTrials.gov registry record · NA
ASV Therapy for Insomnia
A NA study, sponsored by ResMed.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07011966 is a NA study that is actively recruiting participants, run by ResMed. The registered enrollment target is 25 participants.
The verdict
NCT07011966, a NA study, is actively recruiting participants, sponsored by ResMed.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.
Interventions
- DEVICE ASV therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07011966
The ClinicalTrials.gov registry entry for NCT07011966 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASV therapy is the first listed.
NCT07011966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07011966 about?
NCT07011966 is a clinical study titled "ASV Therapy for Insomnia". This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.
What is the current status of trial NCT07011966?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-03-01. Estimated completion is 2027-02.
What interventions are being tested in trial NCT07011966?
The interventions under investigation include: ASV therapy (DEVICE).
Who is sponsoring clinical trial NCT07011966?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.